79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of hospitalization for infants. Several vaccine strategies for RSV are being developed. Among those, live attenuated vaccine (LAV) represent an attractive alternative for young children as they mimic natural infection and induce protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Taveras, Jeanette, Garcia-Maurino, Cristina, Mertz, Sara, Peeples, Mark E, Ramilo, Octavio, Mejias, Asuncion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809030/
http://dx.doi.org/10.1093/ofid/ofz359.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809030/
http://dx.doi.org/10.1093/ofid/ofz359.003

Ejemplares similares